Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyelocytic leukemia (APL) cells in vitro and in patients. However, APL cells develop resistance to retinoic acid treatment. Arsenic trioxide (As2O3) can induce clinical remission in patients with APL, including those who have relapsed after retinoic acid treatment, by inducing apoptosis (programmed cell death) of the leukemia cells. In this study, we investigated the molecular mechanisms by which As2O3 induces apoptosis in retinoic acid-sensitive NB4 APL cells, in retinoic acid-resistant derivatives of these cells, and in fresh leukemia cells from patients.

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells / W. Shao, M. Fanelli, F. F. Ferrara, R. Riccioni, A. Rosenauer, K. Davison, W. W. Lamph, S. Waxman, P. G. Pelicci, F. Lo Coco, G. Avvisati, U. Testa, C. Peschle, C. Gambacorti-Passerini, C. Nervi, W. H. Miller. - In: JOURNAL OF THE NATIONAL CANCER INSTITUTE. - ISSN 0027-8874. - 90:2(1998 Jan 21), pp. 124-33-133.

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

P.G. Pelicci;
1998

Abstract

Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyelocytic leukemia (APL) cells in vitro and in patients. However, APL cells develop resistance to retinoic acid treatment. Arsenic trioxide (As2O3) can induce clinical remission in patients with APL, including those who have relapsed after retinoic acid treatment, by inducing apoptosis (programmed cell death) of the leukemia cells. In this study, we investigated the molecular mechanisms by which As2O3 induces apoptosis in retinoic acid-sensitive NB4 APL cells, in retinoic acid-resistant derivatives of these cells, and in fresh leukemia cells from patients.
Apoptosis; Blotting, Northern; Electrophoresis, Polyacrylamide Gel; Humans; Transglutaminases; Blotting, Western; Receptors, Retinoic Acid; Tumor Cells, Cultured; Down-Regulation; Antineoplastic Combined Chemotherapy Protocols; Leukemia, Promyelocytic, Acute; Tretinoin; Flow Cytometry; Arsenicals; Oxides
Settore MED/04 - Patologia Generale
21-gen-1998
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/195840
Citazioni
  • ???jsp.display-item.citation.pmc??? 64
  • Scopus 329
  • ???jsp.display-item.citation.isi??? 318
social impact